Preclinical proof of concept for VivoVec, a lentiviral-based platform for in vivo CAR T-cell engineeringKathryn Michels, Shon Green, Alissa Brandes et al.|Journal for ImmunoTherapy of Cancer|2023Cited by 108
438 In vivo Engineered CAR-T cells for oncology using a surface-engineered lentivirus platform: nonclinical safety and biodistributionAlissa Brandes, Ryan Larson, Soo Min Koo et al.|Regular and Young Investigator Award Abstracts|2023Cited by 1